Therini Bio
Therapeutics targeting fibrin-mediated innate immune activation
- Sector
- Biotech
- Headquarters
- SACRAMENTO, CA
- Founded
- 2016
- Latest Form D
- $26.6M, Apr 2023
- Total capital
- $29M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $29M
- 2 Form D · last Apr 2023
- 42 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 20 pending · first 2025
- Rank in peer group#481 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$26.6M
- Private capital raisedForm D · SEC · 1st filing$2.4M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#481 · top 33%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Jeffrey D StavenhagenResearcherExecutive OfficerLinked by 1 patent
- Aikaterini AkasoglouDirectorNamed in SEC Form D filings
- Daniel D BurgessDirectorNamed in SEC Form D filings
- David D DolbyDirectorNamed in SEC Form D filings
- Houman D AshrafianDirectorNamed in SEC Form D filings
- Jeffrey Stavenhagen, Ph.D.Executive OfficerNamed in SEC Form D filings
Show all 14 people
- Laia D Crespo-MartinDirectorNamed in SEC Form D filings
- Laurence BarkerDirectorNamed in SEC Form D filings
- Leslie D SchulzeExecutive OfficerNamed in SEC Form D filings
- Michael QuigleyExecutive Officer, DirectorNamed in SEC Form D filings
- Michael D RossDirectorNamed in SEC Form D filings
- Olga D DanilchankaDirectorNamed in SEC Form D filings
- Tara NickersonExecutive Officer, DirectorNamed in SEC Form D filings
- Tracy SaxtonDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 21- PendingMulti-specific Antigen Binding Proteins Which Bind Human Fibrin Or Fibrinogen Yc Domain And Vascular Endothelial Growth Factor And Methods Of UseUSPTOApplication 19117771
- GrantedANTIBODIES WHICH BIND HUMAN FIBRIN OR FIBRINOGEN yC DOMAIN AND METHODS OF USEUSPTOUS 12,269,894
- PendingANTIBODIES WHICH BIND HUMAN FIBRIN OR FIBRINOGEN yC DOMAIN AND METHODS OF USEUSPTOApplication 18571096
Show all 21 patent records
- Multi-specific Antigen Binding Proteins Which Bind Human Fibrin Or Fibrinogen Yc Domain And Vascular Endothelial Growth Factor And Methods Of UseApr 23, 2026 · Application 19117771Pending
- ANTIBODIES WHICH BIND HUMAN FIBRIN OR FIBRINOGEN yC DOMAIN AND METHODS OF USEApr 8, 2025 · US 12,269,894Granted
- ANTIBODIES WHICH BIND HUMAN FIBRIN OR FIBRINOGEN yC DOMAIN AND METHODS OF USEAug 22, 2024 · Application 18571096Pending
- ANTIBODIES WHICH BIND HUMAN FIBRIN OR FIBRINOGEN yC DOMAIN AND METHODS OF USEAug 22, 2024 · Application 18571091Pending
- DOSES OF ANTIBODIES WHICH BIND HUMAN FIBRIN yC OR FIBRINOGEN yC DOMAIN FOR OCULAR DISEASESApplication 63642155Pending
- Multi-specific Antigen Binding Proteins Which Bind Human Fibrin or Fibrinogen yC Domain and Vascular Endothelial Growth Factor and Methods of UseApplication 63573364Pending
- Multi-specific Antigen Binding Proteins Which Bind Human Fibrin Or Fibrinogen ?c Domain And Vascular Endothelial Growth Factor And Methods Of UseApplication PCTUS2023075837Pending
- Multi-specific Antigen Binding Proteins Which Bind Human Fibrin Or Fibrinogen ?c Domain And Vascular Endothelial Growth Factor And Methods Of UseApplication PCTUS2023075840Pending
- Multi-Specific Antigen Binding Proteins Which Bind Human Fibrin or Fibrinogen yC Domain and Vascular Endothelial Growth Factor and Methods of UseApplication 63412833Pending
- Multi-specific Antigen Binding Proteins Which Bind Human Fibrin or Fibrinogen yC Domain and Vascular Endothelial Growth Factor and Methods of UseApplication 63412836Pending
- Antibodies Which Bind Human Fibrien Fibrinogen Yc Domain And Methods Of UseApplication PCTUS2022034189Pending
- Antibodies Which Bind Human Fibrin Or Fibrinogen Yc Domain And Methods Of UseApplication PCTUS2022034188Pending
- Antibodies Which Bind Human Fibrin And Methods Of UseApplication PCTUS2022013423Pending
- Antibodies Which Bind Human Fibrin or Fibrinogen gamma-C Domain and Methods of UseApplication 63212409Pending
- Antibodies Which Bind Human Fibrin or Fibrinogen gamma-C Domain and Methods of UseApplication 63212414Pending
- Anti-Fibrin AntibodiesApplication 63140138Pending
- Doses Of Antibodies Which Bind Human Fibrin C Or Fibrinogen C Domain For Ocular DiseasesApplication PCTUS2025027463Pending
- Multi-specific Antigen Binding Proteins Which Bind Human Fibrin Or Fibrinogen Yc Domain And Vascular Endothelial Growth Factor And Methods Of UseApplication 19117756Pending
- Doses Of Antibodies Which Bind Human Fibrin C Or Fibrinogen C Domain For Neurodegenerative DiseasesApplication PCTUS2025027460Pending
- Multi-specific Antigen-binding Proteins Which Bind Human Fibrin Yc Or Fibrinogen Yc Domain And Vascular Endothelial Growth Factor And Methods Of UseApplication PCTUS2025022714Pending
- DOSES OF ANTIBODIES WHICH BIND HUMAN FIBRIN yC OR FIBRINOGEN yC DOMAIN FOR NEURODEGENERATIVE DISEASESApplication 63642154Pending
Related companies, and why
- Nexo TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Cadrenal Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Immunitas TherapeuticsSimilar federal contract value in Biotech · null in contracts
- EnteroBiotix LTDSimilar federal contract value in Biotech · null in contracts
- Verdezyne IncSimilar federal contract value in Biotech · null in contracts
- New Culture Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .